For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...

As the American Urological Association (AUA) annual meeting prepares to kick off on May 12, newly published prostate cancer guidelines recommend two tests to help clinicians and patients determine the ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today the ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today two ...

CLEVELAND - For men age 50 and over, the PSA, or prostate-specific antigen blood test, has been the recommended screening test for prostate cancer for years. It's also a test that some experts have ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

Regulatory milestone positions Cleveland Diagnostics for faster transition from FDA approval to commercial expansion of its novel prostate cancer test Cleveland Diagnostics, Inc., a commercial-stage ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...

Cleveland Diagnostics, whose first offering is a test for prostate cancer, will donate $3 to the nonprofit Zero Prostate Cancer just because this reporter downloaded ‘A PSA on PSA’ fact sheet from ...

CLEVELAND, May 12, 2026--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a commercial-stage precision oncology company, recently received ISO 13485:2016 certification, the globally recognized standard ...